Pyrrolidine → HCID 68622093, compound
Reaction equation
C([N:3]([CH:7]([CH3:9])C)[CH:4]([CH3:6])C)C.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1.[C:34]([O:38][C:39]([NH:41][CH:42]1[CH:59]([C:60]([OH:62])=O)[CH2:58][N:45]2[CH2:46][CH2:47][C:48]3[C:53]([CH:44]2[CH2:43]1)=[CH:52][C:51]([O:54][CH3:55])=[C:50]([O:56][CH3:57])[CH:49]=3)=[O:40])([CH3:37])([CH3:36])[CH3:35].N1CCCC1>CN(C=O)C>[C:34]([O:38][C:39](=[O:40])[NH:41][CH:42]1[CH:59]([C:60]([N:3]2[CH2:4][CH2:6][CH2:9][CH2:7]2)=[O:62])[CH2:58][N:45]2[CH2:46][CH2:47][C:48]3[C:53]([CH:44]2[CH2:43]1)=[CH:52][C:51]([O:54][CH3:55])=[C:50]([O:56][CH3:57])[CH:49]=3)([CH3:37])([CH3:36])[CH3:35]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
N-Ethyldiisopropylamine (96 mg, 0.74 mmol) and O-(7-Azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU, 103 mg, 0.27 mmol) were added at r.t. to a suspension of (RS,RS,RS)-2-tert-butoxycarbonylamino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline-3-carboxylic acid (100 mg, 0.25 mmol) in N,N,dimethylformamide (2 mL), then after 45 min pyrrolidine (19 mg, 0.27 mmol) was added. The homogeneous solution was stirred 90 min at r.t., then partitioned between hexane/ethyl acetate 1:1 and water. The organic layer was washed with brine, dried (MgSO4), and evaporated, and the residue chromatographed (SiO2, CH2Cl2/MeOH/NH4OH 80:1:0.2) to produce the title compound (58 mg, 51%). Light yellow solid, MS (ISP) 460.5 (M+H)+.
Workup
- custompartitioned between hexane/ethyl acetate 1:1 and water
- washThe organic layer was washed with brine
- dry with materialdried (MgSO4)
- customevaporated
- customthe residue chromatographed (SiO2, CH2Cl2/MeOH/NH4OH 80:1:0.2)
Sources & evidence
- ORD record
- ord-91541ecf82294c18b1a0fd76311f924d
- Source dataset
- uspto-grants-2006_10
- Patent number
- US07122555B2
Reaction notes
Loading…